Chemoreduction with topotecan and vincristine: Quantifying tumor response in bilateral retinoblastoma patients.

King, Benjamin A; Sahr, Natasha; Sykes, April; Wilson, Matthew W; Brennan, Rachel C

King, Benjamin A; Sahr, Natasha; Sykes, April; Wilson, Matthew W; Brennan, Rachel C.

Afiliação

King BA; Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center, College of Medicine, Memphis, Tennessee.
Sahr N; Department of Surgery, St. Jude Children's Research Hospital, Memphis, Tennessee.
Sykes A; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.
Wilson MW; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.
Brennan RC; Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center, College of Medicine, Memphis, Tennessee.

Pediatr Blood Cancer ; 68(4): e28882, 2021 04.

Article em En | MEDLINE | ID: mdl-33507604

Assuntos

Antineoplásicos/uso terapêutico; Neoplasias da Retina/tratamento farmacológico; Retinoblastoma/tratamento farmacológico; Topotecan/uso terapêutico; Vincristina/uso terapêutico; Adolescente; Criança; Pré-Escolar; Feminino; Humanos; Lactente; Masculino; Neoplasias da Retina/patologia; Retinoblastoma/patologia; Resultado do Tratamento; Carga Tumoral/efeitos dos fármacos

Palavras-chave

bilateral retinoblastoma; chemoreduction; neoadjuvant chemotherapy; topotecan; tumor volume

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retinoblastoma / Vincristina / Neoplasias da Retina / Topotecan / Antineoplásicos Tipo de estudo: Guideline / Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google